<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0124-8146</journal-id>
<journal-title><![CDATA[Investigaciones Andina]]></journal-title>
<abbrev-journal-title><![CDATA[Investig. andina]]></abbrev-journal-title>
<issn>0124-8146</issn>
<publisher>
<publisher-name><![CDATA[Fundación Universitaria del Área Andina - FUNANDI]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0124-81462018000200151</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[PERFIL CLÍNICO Y EPIDEMIOLÓGICO DE PACIENTES CON ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA HOSPITALIZADOS EN UN CENTRO DE ALTA COMPLEJIDAD DE LA CIUDAD DE MEDELLÍN, COLOMBIA, DURANTE EL AÑO 2015]]></article-title>
<article-title xml:lang="en"><![CDATA[CLINICAL AND EPIDEMIOLOGICAL PROFILE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE HOSPITALIZED IN A HIGH COMPLEXITY CENTER OF THE CITY OF MEDELLÍN, COLOMBIA, IN 2015]]></article-title>
<article-title xml:lang="pt"><![CDATA[PERFIL CLÍNICO E EPIDEMIOLÓGICO DOS PACIENTES COM DOENÇA PULMONAR OBSTRUTIVA CRÔNICA (DPOC) HOSPITALIZADOS EM UM CENTRO DE ALTA COMPLEXIDADE DA CIDADE DE MEDELLÍN, COLÔMBIA, DURANTE O ANO 2015]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Agudelo Vélez]]></surname>
<given-names><![CDATA[Camilo Andrés]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez Sánchez]]></surname>
<given-names><![CDATA[Lina María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ortiz Trujillo]]></surname>
<given-names><![CDATA[Isabel Cristina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez Gázquez]]></surname>
<given-names><![CDATA[María de los Ángeles]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zuluaga Quintero]]></surname>
<given-names><![CDATA[Mónica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Perilla Hernández]]></surname>
<given-names><![CDATA[Natalia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández Restrepo]]></surname>
<given-names><![CDATA[Felipe]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Quintero Moreno]]></surname>
<given-names><![CDATA[Dayana Andrea]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ruiz Mejía]]></surname>
<given-names><![CDATA[Camilo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aristizábal Giraldo]]></surname>
<given-names><![CDATA[María Alejandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Pontificia Bolivariana Facultad de Medicina ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Pontificia Bolivariana Facultad de Medicina ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Pontificia Bolivariana Facultad de Medicina ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de Antioquia  ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Universidad Pontificia Bolivariana  ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,Universidad Pontificia Bolivariana  ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>20</volume>
<numero>37</numero>
<fpage>151</fpage>
<lpage>160</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0124-81462018000200151&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0124-81462018000200151&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0124-81462018000200151&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción. La enfermedad pulmonar obstructiva crónica (EPOC) es una condición que cursa con limitación del flujo aéreo espiratorio e inflamación crónica de las vías aéreas, y que representa un problema de salud pública a nivel mundial.  Objetivo. Determinar el perfil clínico y epidemiológico de pacientes con EPOC en una institución hospitalaria de la ciudad de Medellín, Colombia.  Metodología. Se realizó un estudio transversal, con una muestra de 50 pacientes, con diagnóstico clínico o espirométrico de enfermedad pulmonar obstructiva crónica, atendidos de forma intrahospitalaria en una institución privada en Medellín durante el año 2015. A las variables cuantitativas se les calculó el promedio, desviación estándar y valores mínimo y máximo. A las cualitativas, medidas de nivel nominal y ordinal y se les estimaron proporciones.  Resultados. La edad promedio fue de 73,5±9,3 años, el 52% fueron mujeres. El promedio de tiempo de diagnóstico fue de 7,8±1,3 años. Las características clínicas más frecuentes fueron las siguientes: el 36% tenía como clasificación estadio D para la enfermedad, el 34% tenía VEF1 &lt;30%, el 88% tenían antecedente de tabaquismo y el 52% utilizaba oxígeno en casa.  Conclusiones. La mayoría de nuestra población fue clasificada como GOLD categoría D, con una limitación grave del flujo aéreo espiratorio (VEF1 &lt; 30%) y requerimiento de uso de oxígeno domiciliario. Lo anterior indica un inadecuado control de la enfermedad, debido, probablemente, al contexto intrahospitalario de los pacientes incluidos en el estudio.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction. Chronic Obstructive Pulmonary Disease (COPD) is a condition that limits the air flow and produce chronic inflammation of the airways, which represents a public health problem worldwide.  Objective. To determine the clinical and epidemiological profile of patients with COPD in a hospital of the city of Medellin, Colombia.  Methodology. A cross-sectional study was carried out, with a sample of 50 subjects, who had a clinical or spirometric diagnosis of Chronic Obstructive Pulmonary Disease, receiving Inpatient care in a private institution in Medellin in 2015. It was calculated on quantitative variables, the average, standard deviation and minimum and maximum values. It was estimated on qualitative variables, measures of nominal and ordinal level and proportions.  Results. The average age was 73.5 ) 9,3 years, 52% were women. The average of Diagnostic time was 7.8 ) 1,3 years. The most common clinical characteristics were the following: 36% had a stage D classification for the disease, 34% had FEV1 &lt;30%, 88% had a smoking history and 52% used oxygen at home.  Conclusions. The majority of our population was classified as GOLD category D, with a severe limitation to breath (FEV1 &lt;30%) and had to use oxygen at home. The foregoing indicates that there is an inadequate control of the disease, due to the inpatient environment of the subjects involved in the study.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução. A doença pulmonar obstrutiva crônica (DPOC) é uma condição caracterizada por fluxo respiratório limitado e inflamação crônica das vias aéreas, e representa um problema de saúde pública em todo o mundo. Objetivo. Determinar o perfil clínico e epidemiológico dos pacientes com DPOC em uma instituição hospitalar da cidade de Medellín, Colômbia.  Metodologia. Foi realizado um estudo transversal, com uma amostra de 50 pacientes, com diagnóstico clínico e espirométrico da doença pulmonar obstrutiva crônica, que receberam atenção hospitalar em uma instituição privada em Medellín durante o ano de 2015. Para as variáveis quantitativos foram calculados a média, desvio padrão e valores mínimo e máximo. Para medidas qualitativas de nível nominal e ordinal se estimaram proporções.  Resultados. A idade média foi de 73,5 ± 9,3 anos, 52% eram mulheres. A média do tempo de diagnóstico foi de 7,8 ± 1,3 anos. As características clínicas mais frequentes foram: 36% tinham classificação no estádio D para a doença, 34% tinham VEF1 &lt;30%, 88% tinham história de tabagismo e 52% usavam oxigênio em casa.  Conclusões. A maioria da nossa população foi classificada como GOLD categoria D, com uma limitação severa do fluxo de ar (VEF1 &lt;30%) e exigência de uso de oxigênio domiciliar. O que precede indica um controle inadequado da doença, devido, provavelmente, ao contexto hospitalar dos pacientes incluídos no estudo.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[espirometría]]></kwd>
<kwd lng="es"><![CDATA[tabaquismo, disnea, enfermedad pulmonar obstructiva crónica]]></kwd>
<kwd lng="en"><![CDATA[spirometry]]></kwd>
<kwd lng="en"><![CDATA[smoking, dyspnea, chronic obstructive pulmonary disease]]></kwd>
<kwd lng="pt"><![CDATA[espirometria]]></kwd>
<kwd lng="pt"><![CDATA[tabagismo]]></kwd>
<kwd lng="pt"><![CDATA[dispneia]]></kwd>
<kwd lng="pt"><![CDATA[doença pulmonar obstrutiva crônica]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pavod]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2017</year>
<volume>377</volume>
<numero>17</numero>
<issue>17</issue>
<page-range>1613-29</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roversi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Corbetta]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Clini]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[GOLD 2017 recommendations for COPD patients: toward a more personalized approach]]></article-title>
<source><![CDATA[COPD Research and Practice]]></source>
<year>2017</year>
<volume>3</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vogelsinger]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy and safety of nasal high-flow oxygen in COPD patients]]></article-title>
<source><![CDATA[BMC Pulm Med]]></source>
<year>2017</year>
<volume>17</volume>
<numero>143</numero>
<issue>143</issue>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2017</year>
<volume>377</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>923-35</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pineda]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Cadavid]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calidad de vida en pacientes con Enfermedad Pulmonar Obstructiva]]></article-title>
<source><![CDATA[Universidad y Salud]]></source>
<year>2016</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>482-93</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[WC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study]]></article-title>
<source><![CDATA[NPJ Prim Care Respir Med]]></source>
<year>2015</year>
<volume>25</volume>
<page-range>15063</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calle]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Morales]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exacerbación de la EPOC]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2010</year>
<volume>46</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>21-5</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leung]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Sin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2017</year>
<volume>358</volume>
<page-range>1-14</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Smoking duration, respiratory symptoms, and COPD in adults aged &gt;45 years with a smoking history]]></article-title>
<source><![CDATA[Int J Chron Obstruct Pulmon Dis]]></source>
<year>2015</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1409-16</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bozek]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Rogala]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Bednarski]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Asthma, COPD and comorbidities in elderly people]]></article-title>
<source><![CDATA[J Asthma]]></source>
<year>2016</year>
<volume>53</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>943-7</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mitsiki]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study]]></article-title>
<source><![CDATA[Int J Chron Obstruct Pulmon Dis]]></source>
<year>2015</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1371-82</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blasi]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical Characterization and Treatment Patterns for the Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease with Severe or Very Severe Airflow Limitation]]></article-title>
<source><![CDATA[COPD]]></source>
<year>2017</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>15-22</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sinha B.]]></surname>
<given-names><![CDATA[Vibha]]></given-names>
</name>
<name>
<surname><![CDATA[Singla R.]]></surname>
<given-names><![CDATA[Chowdhury R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An epidemiological profile of chronic obstructive pulmonary disease: a community-based study in Delhi]]></article-title>
<source><![CDATA[J Postgrad Med]]></source>
<year>2017</year>
<volume>63</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>29-35</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li-Cher]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Choo-Khoon]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Detailed characterization of hospitalized COPD patients in relation to combined COPD assessment by GOLD]]></article-title>
<source><![CDATA[Chronic Obstructive Pulmonary Diseases]]></source>
<year>2016</year>
<volume>1</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
